The decision to form neural tissue or not is a binary choice that requires the repression of the alternative fate of ventral epidermal cells and that depends on threshold activity levels of several growth factors, including bone morphogenic protein 4 (BMP4) (8) . In Xenopus laevis, this fate is determined by the Spemann's organizer, located on the dorsal side of the gastrula, which is a source of secreted neural inducers such as Chordin, Noggin, and Follistatin. These molecules create a gradient of BMP activity by antagonizing BMP signaling in the anterior ectoderm of the embryo, and this BMP gradient establishes a dorsoventral pattern underlying the neural structure, cement gland, and epidermis (5) . The organizer region also secretes a number of other antagonists of growth factor signaling, including Wnt inhibitors Frzb-1, crescent, and Dkk-1 and the Nodal inhibitor Cerberus. In the current model, the simultaneous inhibition of both BMP (5) and Wnt (18) signaling pathways is required for anterior neural induction. Additionally, instructive cues from fibroblast growth factor (12) and insulin-like growth factor (32) signaling pathways have been reported to actively contribute to anterior neural specification. In Xenopus, signals from the dorsal mesoderm induce the anteroposterior pattern of the overlying ectoderm during gastrulation, which is converted into the central nervous system as well as the nonneural cement gland. These structures are organized along an anterior-posterior axis in which the cement gland is the most anterior ectodermal structure. The development of all neural tissue initially proceeds toward anterior fates, and all such tissue would develop into forebrain and midbrain tissue and cement glands if not subjected to inhibition. However, these anterior fates are diverted toward more-posterior fates: development into hindbrain and spinal chord tissue (5, 8, 37) .
Nemo-like kinase (NLK) is an evolutionarily conserved serinethreonine protein kinase that was originally isolated as a murine orthologue of the Drosophila melanogaster Nemo, which plays a role in diverse signaling processes (2) . Studies of Nemo null mutants of Drosophila revealed that Nemo plays a role in head development and the epithelial planar cell polarity pathway during eye development by controlling programmed cell death (25) . In our previous studies, we demonstrated that NLK is involved in the suppression of Wnt/␤-catenin signaling pathways. NLK inactivates a transcriptional unit composed of ␤-catenin-T-cell factor/ lymphoid enhancer factor (TCF/LEF) by phosphorylating TCF/ LEF, and this inactivation results in the inhibition of its binding to target gene sequences (15, 40) . NLK functions downstream of transforming growth factor ␤-activated kinase 1, a member of the mitogen-activated protein kinase (MAPK) kinase kinase family (15, 29) ; Wnt1 (14) ; and Wnt5a (16) . The loss of NLK/Nemo function results in a lethal phenotype in Drosophila (25) , Caenorhabditis elegans (33) , and mouse (19) embryos, strongly implicating NLK/Nemo as a very important regulator of cell growth, patterning, and death. We previously demonstrated that in Xenopus embryos, the expression of NLK is restricted to the central nervous system, eye field, and anterior neural crest cell populations. Xenopus NLK (xNLK) induces the expression of anterior neural marker genes, such as those for Otx2 and the neural cell adhesion molecule (N-CAM), and associates with the high-mobility group domain transcription factor xSox11 (13) . Our recent data indicate that, in addition to TCF/LEF and xSox11, NLK associates with and modulates the activities of other transcription factors, including STAT3 (29) and HMG2L1 (39) . This finding suggests that NLK contributes to various signaling pathways via its ability to interact with a diverse collection of transcription factors.
Myocyte enhancer factor 2 (MEF2) proteins are members of the MADS (MCMI, agamous, deficiens, and serum response factor) box family of transcription factors. MEF2, originally identified as a transcription factor present at high levels in muscle tissue, binds to an A/T-rich DNA sequence in the control regions of numerous muscle-specific genes and, in particular, cooperates with members of the MyoD family in specifying the differentiation of skeletal muscle (1, 3, 38) . Emerging evidence has shown that MEF2 proteins constitute a family of transcription factors that play critical roles in the processes of cell differentiation during the development of multicellular organisms (24) . Mammalian MEF2 proteins are encoded by four genes (those for MEF2A, MEF2B, MEF2C, and MEF2D), which exhibit isoform-specific or overlapping patterns of expression in both embryonic and adult tissues. Structurally, the MEF2 proteins comprise highly homologous amino termini that mediate MEF2 homo-and heterodimerization and DNA binding, while the carboxyl termini are more divergent and contain the transactivation domain (1) . All MEF2 family members are expressed at high levels in neurons in the central nervous system. The expression of all MEF2s increases in differentiating neurons during brain development (22) . Although recent in vitro findings support the hypothesis that MEF2 family members regulate neuronal survival and development, little is known about the exact functions of MEF2s during early neuronal development in embryos.
MEF2 family molecules are the targets for several key intracellular signaling pathways. In this regard, the involvement of p38 MAPK (41), extracellular signal-regulated kinase 5 (ERK5) (17) , cyclin-dependent kinase 5 (CDK5) (9) , and protein kinase A (36) in these processes has been well known. However, the dynamic changes in MEF2 phosphorylation during diverse cellular processes such as neuronal survival and apoptosis strongly suggest that the regulation of MEF2 is more complex, raising the possibility of the involvement of yet-unidentified kinases and phosphatases (7, 10, 23, 30, 35) .
In the present study, we first identified the MEF2A transcription factor as a novel partner for NLK. xNLK directly phosphorylated Xenopus MEF2A (xMEF2A) at Thr 297 and Ser 340 , and the endogenous phosphorylation of MEF2A was inhibited by the depletion of endogenous NLK. The depletion of either xNLK or xMEF2A resulted in a defect in anterior neural development, including the loss of eye and head structures in Xenopus embryos. The phenotypes induced by endogenous xMEF2A depletion were reversed by the overexpression of wild-type xMEF2A but not by that of mutant xMEF2A harboring mutations in the NLK phosphorylation sites. These results reveal a new mechanism for regulating anterior formation by NLK-MEF2A signaling that involves the phosphorylation of MEF2A.
MATERIALS AND METHODS
Plasmid construction. The xMEF2A cDNA was kindly provided by N. Ueno (National Institute for Basic Biology). The human MEF2A and xMEF2C and xMEF2D cDNAs were amplified by reverse transcription-PCR (RT-PCR) from cDNA templates prepared from 293 cells and Xenopus embryo tissue, respectively, and were subcloned into the CS2ϩ vector.
Embryo handling and MO. Capped mRNAs were synthesized from linearized vectors using the mMessage machine kit (Ambion). mRNAs were then injected into the animal blastomeres of embryos. Animal cap explants were removed at the late blastula stage and allowed to grow until control sibling embryos reached the neurula stage. The morpholino oligonucleotides (MO; Gene Tools, LLC) used here were 5Ј-GCCCTTCCCTACACGGATGTCCCCC-3Ј (xNLK MO) (28), 5Ј-CATGGTTGCGTTGTTCTCTCCC-3Ј (xMEF2A MO), 5Ј-CCATAGT CCCCGTTTTTCTGTCTTC-3Ј (xMEF2C MO), and 5Ј-AATCTGGATCTTTT TTCTGCCCATG-3Ј (xMEF2D MO). MO for xMEF2A, xMEF2C, or xMEF2D specifically inhibited the translation of mRNA for xMEF2A, xMEF2C, or xMEF2D, respectively.
RT-PCR analysis. Total RNA was prepared using TRIzol (Invitrogen). cDNA synthesis was carried out using Moloney murine leukemia virus reverse transcriptase (Invitrogen). The sequences of the primer pairs were as described previously (13) and as follows: Pax6, 5Ј-CAGAACATCTTTTACCCAGGA-3Ј and 5Ј-ACTACTGCTAATGGGAATGTG-3Ј; Lhx2, 5Ј-GTCTTCAGCTTGCC CCCTCTCCTTCT-3Ј and 5Ј-GGTCGGGTTCCTGTGTTGCTTCTT-3Ј; Rx1, 5Ј-CCCCAACAGGAGCATTTAGAAGAC-3Ј and 5Ј-AGGGCACTCATGGC AGAAGGTT-3Ј; and Six3, 5Ј-ATGGTGTTCAGGTCCCCTCT-3Ј and 5Ј-GG ATGGACTCGTGTTTATTAATGG-3Ј.
Antibodies. The following antibodies were used for immunoprecipitation and/or Western blotting analysis: anti-FLAG (M2; Sigma), anti-Myc (9B11; Cell Signaling), anti-MEF2A (Santa Cruz) and phospho-Thr312 anti-MEF2A (Signal Antibody Technology), and anti-NLK (16) .
Immunoprecipitation and Western blotting analysis. 293 cells were cultured at 37°C in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum. 293 cells were transfected with the plasmids indicated below by the calcium phosphate precipitation method. After 24 h, cells were lysed in lysis buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 0.5% NP-40, 10 mM NaF, 1 mM Na 3 VO 4 , 1 mM phenylmethylsulfonyl fluoride, 10 g of aprotinin/ml, 10 g of pepstatin/ml, and 20 g of leupeptin/ml). Lysates were precleared with protein G-Sepharose beads (Amersham Biosciences) and immunoprecipitated with the appropriate antibodies. For Western blotting analysis, whole-cell lysates or immunoprecipitates were resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred onto polyvinylidene difluoride membranes (Amersham Biosciences). The membranes were probed with the appropriate antibody, and proteins of interest were visualized with horseradish peroxidase-conjugated mouse or rabbit immunoglobulin G by using Western Lightning chemiluminescence reagent Plus (PerkinElmer Life Science).
Protein identification by LC-MS-MS analysis. FLAG-NLK was expressed in 293 cells, and NLK and associated proteins were recovered from cell extracts by immunoprecipitation with anti-FLAG antibody. The NLK-associated complexes were digested with Achromobacter protease I, and the resulting peptides were analyzed using a nanoscale liquid chromatography-tandem mass spectrometry (LC-MS-MS) system as described previously (26) .
In vitro kinase assay. 293 cells were transfected with the FLAG-NLK expression plasmid. The lysates were prepared from the transfected cells by using lysis buffer and immunoprecipitated with anti-FLAG antibody. Immunoprecipitates were incubated with 1 g of bacterially expressed glutathione S-transferase fusion proteins corresponding to amino acids 217 to 470 of xMEF2A in 20 l of kinase buffer containing 10 mM HEPES (pH 7.4), 1 mM dithiothreitol, 5 mM MgCl 2 , and 5 Ci of [␥- 32 P]ATP at 25°C for 5 min. Phosphorylated substrates were subjected to SDS-PAGE and quantitated using a BAS 2500 image analyzer (Fujifilm).
RNA interference. Neuro2A cells were grown in 12% fetal bovine serum-DMEM with 4.5 g of glucose/liter and 25 mM HEPES (pH 7.4). For differentiation experiments, Neuro2A cells were subjected to serum depletion by replacing the medium with fresh serum-free DMEM and further incubated for the periods indicated below (6) . We designed small interfering RNAs (siRNAs) targeting mouse NLK mRNA (sense, 5Ј-CAGATCCAAGAGATGGAAA-3Ј) along with the corresponding antisense RNA oligonucleotide with two thymidine residues (dTdT) at the 3Ј end of the sequence (Dharmacon). The control siRNA siCONTROL nontargeting siRNA no. 2 (Dharmacon) was used for the negative control. Neuro2A cells were transfected with these siRNAs by using Lipofectamine 2000 according to the instructions of the manufacturer (Invitrogen). Thirty-six hours posttransfection, the medium was replaced with fresh serum-free DMEM to induce the differentiation of Neuro2A cells.
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Whole-mount in situ hybridization. pBluescript vectors containing a fragment of xNLK cDNA encoding the C-terminal region (nucleotides 945 to 1509; GenBank accession no. AB071285) and the 3Ј untranslated region of xMEF2A cDNA (nucleotides 1799 to 2352; GenBank accession no. BC046368) were used as templates to generate digoxigenin-labeled RNA probes with a digoxigenin RNA labeling kit according to the protocol of the manufacturer (Roche). Wholemount in situ hybridization analysis of embryos of various stages was performed with digoxigenin-labeled RNA probes essentially as described by HemmatiBrivanlou et al. (11) with the following modifications. After the manual removal of the vitelline membranes, embryos were fixed in 4% paraformaldehyde in phosphate-buffered saline and dehydrated by gradual washing in methanol. Embryos were rehydrated with phosphate-buffered saline containing 0.1% Triton X-100 and then treated with proteinase K (2 g/ml) for 10 min at ambient temperature, followed by postfixation with 4% paraformaldehyde for 20 min. Hybridization was performed at 68°C with a solution of 50% formamide, 5ϫ SSC (1ϫ SSC is 0.15 M NaCl plus 0.015 M sodium citrate), 2ϫ Denhardt's solution, 200 g of tRNA/ml, 0.1% Triton X-100, and 0.1% CHAPS {3-[(3-cholamidopropyl)-dimethylammonio]-1-propanesulfonate} containing 200 ng of digoxigenin-labeled RNA probe/ml. Color detection was carried out with BM purple (Roche).
RESULTS
NLK is essential for anterior neural development. Our recent studies have shown that xNLK is expressed in neural tissues and induces the expression of the panneural marker N-CAM and the anterior neural marker Otx2 (13) . To examine the in vivo role of xNLK, an antisense MO targeting xNLK (xNLK MO) was injected into Xenopus embryos to inhibit the expression of NLK (data not shown). We injected xNLK MO into the four animal blastomeres of eight-cell-stage Xenopus embryos and examined its effect on neuroectodermal tissue formation. The depletion of endogenous xNLK caused severe defects in the formation of head structures, including the loss of both eyes and the cement gland at the tadpole stages (Fig.  1A) , and reduced the expression of the genes for the neural markers N-CAM and Otx2, cement gland marker XAG1, and the anterior markers Pax6, Lhx2, Rx1, and Six3 (42) (Fig. 1B) . No phenotype was detected upon the injection of up to 20 ng of control MO. The observed defects induced by xNLK MO were eliminated by the coinjection of xNLK mRNA (Fig. 1) , indicating that xNLK is involved in head development.
MEF2A is a novel NLK-associating protein.
To further clarify the functions of NLK during head formation in Xenopus development, we analyzed proteins that immunoprecipitated with FLAG-tagged NLK from 293 cells by LC-MS-MS. We identified the transcription factor MEF2A as a candidate protein that may physically interact with NLK (data not shown).
To confirm this interaction, we performed coimmunoprecipitation using tagged versions of each protein. We found that FLAG-xNLK could be immunoprecipitated with Myc-tagged xMEF2A, and vice versa, when both proteins were expressed in 293 cells ( Fig. 2A and B) . To prove the existence of an endogenous NLK and MEF2A complex in vivo, we prepared extracts from mouse brain and performed coimmunoprecipitation analysis using anti-NLK and anti-MEF2A antibodies. Figure  2C shows that endogenous MEF2A in mouse brain was coimmunoprecipitated with NLK. We conclude that NLK can associate with MEF2A in mammalian cells. Fig. 2A) . To examine whether NLK directly phosphorylates MEF2A, an in vitro kinase assay was performed using bacterially expressed MEF2A protein. Figure 3A shows that glutathione S-transferase-MEF2A was phosphorylated by NLK in a kinase activity-dependent manner. It is known that three phosphorylation residues within the trans-activation domain of MEF2A, Thr 312 , Thr 319 , and Ser 355 in the human protein and Thr 297 , Thr 304 , and Ser 340 in xMEF2A, are involved in the transcriptional activity of MEF2A (17, 41) . In contrast, the phosphorylation of a C-terminal serine residue of MEF2A (Ser 408 in human MEF2A and Ser 393 in xMEF2A) inhibits transcriptional activity (9) . We thus tested whether NLK phosphorylates any of these residues. The replacement of Thr 297 or Ser 340 in xMEF2A with alanine (T 297 A or S 340 A) significantly reduced the level of phosphorylation by xNLK (Fig. 3B) . The replacement of both Thr 297 and Ser 340 with alanine (T 297 A, S 340 A) led to a further reduction in the level of phosphorylation (Fig. 3B) . On the other hand, the replacement of Thr 304 or Ser 393 with alanine had no effect on the levels of xMEF2A phosphorylation. These results indicate that xNLK directly phosphorylates both the Thr 297 and Ser 340 residues of xMEFA. We next examined whether NLK endogenously phosphorylates MEF2A in vivo. The phosphorylation of MEF2A was monitored by Western blotting using an antibody that specifically recognizes the form of MEF2A phosphorylated at the Thr 312 residue in the case of human MEF2A (Thr 297 in xMEF2A). We confirmed that MEF2A was phosphorylated at the Thr 312 residue depending on the kinase activity of NLK when 293 cells were transfected with Myc-tagged human MEF2A with or without FLAG-tagged mouse NLK (Fig. 3C) . We next examined endogenous Thr 312 phosphorylation levels during the differentiation of cells of the Neuro2A line, a mouse neuroblastoma cell line, and found that the phosphorylation of MEF2A at Thr 312 increased during serum depletion-induced differentiation (Fig. 3D) . To assess whether endogenous NLK is involved in this phosphorylation, we performed a knockdown of NLK protein by using siRNA. When Neuro2A cells were transfected with NLK siRNA, the level of endogenous phosphorylation of MEF2A at Thr 312 was significantly lower than To analyze the function of xNLK-xMEF2A signaling in embryonic development, we first confirmed the expression pattern of xMEF2A during Xenopus embryonic development by RT-PCR analysis. We found that xMEF2A was expressed from maternally deposited mRNA and that its zygotic expression was induced after the neurula stage (Fig. 4A) . It is noteworthy that xMEF2A expression in the head region of Xenopus embryos was detected during neural stages and that it parallels the expression of xNLK (Fig. 4B and C) . To address the physiological relationship between xNLK and xMEF2A in the anterior tissues, we synthesized an antisense MO targeting xMEF2A. By Western blotting analysis, we confirmed that the injection of the designed xMEF2A MO specifically reduced the expression of xMEF2A protein (data not shown). When xMEF2A MO was injected into a Xenopus region that develops mainly into neuroectodermal tissues and head structures, the phenotype caused by the depletion of xMEF2A was mainly similar to the phenotype resulting from the injection of NLK MO: incomplete formation of the eyes (Fig. 5A ) and reduced expression of anterior markers such as Pax6, Lhx2, Rx, and Six3; cement gland marker XAG1; and panneural marker N-CAM (Fig. 5B) . xMEF2A functions downstream of xNLK. To examine whether xMEF2A functions downstream of xNLK, we performed animal cap assays. When xNLK mRNA was injected into the animal poles of two-cell embryos, expression of the panneural marker N-CAM was induced in the animal caps, as we have previously reported. Additionally, the expression of the eye marker Xenopus Pax6 was induced by the injection of xNLK mRNA (Fig. 6A) . We found that the induction of both of these markers was inhibited by the injection of xMEF2A MO and restored by coinjection with wild-type xMEF2A mRNA but not with mRNA of the nonphosphorylatable mutant protein. These results suggest that the xNLK-induced expression of N-CAM and Pax6 is mediated by xMEF2A via its phosphorylation. To further confirm that xMEF2A acts downstream of xNLK, we tested whether the overexpression of xMEF2A reversed the effect of xNLK knockdown. When mRNA of Xenopus Chordin, a BMP4 inhibitor, was injected into the animal poles of two-cell embryos, the expression of N-CAM and anterior markers such as Xenopus Pax6, Lhx2, Rx1, and Six3 was induced (Fig. 6B and C) . The injection of xNLK MO or xMEF2A MO inhibited the induction of these markers, and coinjection with NLK or MEF2A mRNA eliminated the defects caused by NLK MO or MEF2A MO, respectively ( Fig. 6B and C) . Interestingly, coinjection with wild-type xMEF2A mRNA also restored the expression of Xenopus Pax6 and Lhx2 but not the expression of Xenopus Rx1, Six3, and N-CAM (Fig. 6B) . On the other hand, coinjection with xMEF2A(T 297 A, S 340 A) mRNA failed to restore the expression of any anterior neural marker examined (Fig. 6B and C) . Moreover, coinjection with xNLK mRNA could not reverse the inhibition of Chordin-induced anterior markers by the depletion of xMEF2A (Fig. 6C) . These results suggest that xMEF2A is partially responsible for the downstream effects of xNLK in Xenopus anterior formation.
xMEF2A functions in a subtype-specific manner. In X. laevis, three isoforms of MEF2, xMEF2A, xMEF2C, and xMEF2D, have been isolated, and we found that the overexpression of xNLK in 293 cells caused electrophoretic mobility retardation of xMEF2A, xMEF2C, and xMEF2D, suggesting that xNLK could phosphorylate any isoforms of the xMEF2 family (data not shown). To examine whether xMEF2A functions specifically in anterior formation, we injected xMEF2C MO or xMEF2D MO into Xenopus embryos. Neither the injection of xMEF2C MO nor that of xMEF2D MO resulted in marked effects on the endogenous expression of anterior markers (Fig. 5B) . Moreover, Chordin-induced expression of Xenopus Pax6, Lhx2, and N-CAM was inhibited by coinjection with xMEF2A MO but not by coinjection with xMEF2C MO or xMEF2D MO (Fig. 6D) . These results suggest that xMEF2A regulates anterior neural development, including eye formation, in a subtype-specific manner.
DISCUSSION
The results of our previous overexpression experiments with animal pole explants indicated that xNLK induces the expression of neural marker genes, including anterior marker genes (13) . In the present study, we identified the transcription factor MEF2A as a novel substrate of the MAPK-like serine-threonine kinase NLK and showed that NLK-MEF2A signaling controls anterior neural development in Xenopus. The depletion of either xNLK or xMEF2A resulted in severe defects in anterior neural development, including the loss of eye formation. These observed defects induced by xMEF2A depletion were abolished by wild-type xMEF2A but not by the nonphosphorylatable mutant protein [xMEF2A(T 297 A, S 340 A)], indicating that xMEF2A functions downstream of xNLK in the development of anteroneural structures. Our results demonstrate new roles of xNLK-xMEF2A signaling in the regulation of endogenous anterior tissue development, including eye formation, in Xenopus.
It is well known that the phosphorylation of MEF2 is critical 297 and Ser 340 , which are residues in xMEF2A critical for its activation (Fig. 3) . The observed eye defects induced by the depletion of endogenous xMEF2A could be abolished by coinjection with wild-type xMEF2A mRNA but not with mRNA of the nonphosphorylatable mutant MEF2A(T 297 A, S 340 A). Moreover, the endogenous phosphorylation of MEF2A was inhibited by the depletion of endogenous NLK in neuronal cells (Fig. 3D) . These findings provide the first evidence that xNLK regulates anterior development via the phosphorylation of xMEF2A. By contrast, xNLK did not phosphorylate Thr 304 of xMEF2A, which is a potential target of p38␣ and ERK5. Of note, Nishimoto et al. recently reported that the depletion of MEK5 or ERK5 in Xenopus embryos resulted in defects in anterior head structures, including the loss of the eyes (28) , apparently similar to the phenotypes we observed following the depletion of xNLK or xMEF2A. Therefore, it will be necessary to examine whether xNLK and Xenopus ERK5 may cooperatively regulate anterior development via the activation of xMEF2A.
Since we injected xNLK MO or xMEF2A MO into the animal regions of eight-cell-stage embryos, we cannot rule out the possible interference of xNLK or xMEF2A depletion with the activity of the Spemann organizer and anterior endomesoderm. These are two regions involved in the patterning of the dorsoanterior axis that could affect the formation of the anterior head structure. However, in the whole embryos and Chordin-injected ectodermal explants, we observed that the depletion of endogenous xNLK or xMEF2A reduced the expression of the specific anterior marker genes (those for Xenopus Pax6, Lhx2, Rx1, and Six3) and the panneural marker N-CAM ( Fig.  5B and 6B, C, and D) . In addition, embryos depleted of xMEF2A exhibited no apparent effects on the expression of mesodermal markers such as Brachyury (Xbra) or ␣-actin (data not shown). Moreover, endogenous NLK is required for the phosphorylation of MEF2A in both cultured cells and Xenopus embryos (Fig. 3D) . The NLK-or Chordin-induced anterior markers were inhibited by the injection of xMEF2A MO and restored by coinjection with wild-type xMEF2A mRNA but not with mRNA of the nonphosphorylatable mutant protein (Fig. 6A and C) . Furthermore, coinjection with xNLK mRNA could not reverse the inhibition of Chordininduced anterior markers by the depletion of xMEF2A (Fig.  6C) . Taken together, these results suggest that MEF2A mediates in part the effect of NLK on anterotissue development. On the other hand, the inhibition of Xenopus Pax6 and Lhx2 expression could be rescued by the wild-type xMEF2A but not by the nonphosphorylated mutant protein in the Chordin-injected animal caps (Fig. 6B ) in which the endogenous NLK was depleted. This may be due to the existence of other potential MEF2A activators, such as p38␣ (41) and ERK5 (17, 28) , that could compensate for NLK activity. In contrast, the overexpression of wild-type xMEF2A failed to induce the expression of Xenopus Rx1, Six3, and N-CAM genes (Fig. 6) , suggesting that the endogenous expression of Xenopus Rx1, Six3, and N-CAM genes is absolutely dependent on the presence of NLK but not other kinases.
In Xenopus, three isoforms of the MEF2 family have been identified: xMEF2A, xMEF2C, and xMEF2D. Studies of mammalian MEF2 molecules suggest that different isoforms may overlap in their biological functions (1, 10, 24) . Therefore, we examined whether other isoforms of xMEF2, xMEF2C and xMEF2D, may also be involved in xNLK-xMEF2A-mediated anterior formation. We found that neither the depletion of xMEF2C nor that of xMEF2D affected the expression of any anterior marker genes, whereas the depletion of endogenous xMEF2A blocked the induction of these markers ( Fig. 5B and  6D) . Thus, xMEF2A appears to be selectively responsible for regulating certain anterior marker genes downstream of xNLK. Other studies have also demonstrated possible functional specificity among different isoforms of the MEF2 family (20, 21, 27) . For example, MEF2A and MEF2D, but not MEF2C or MEF2B, function as prosurvival factors with high levels of transcriptional activity in postmitotic cerebellar granule neurons (20) . Studies of MEF2A and MEF2C null mice have indicated that MEF2C plays an essential role in cardiomyogenesis in early development (prior to looping morphogenesis) and that MEF2A fulfills specific roles in maintaining appropriate mitochondrial content and cytoarchitectural integrity in the postnatal heart (21, 27) . However, studies of these null mice have reported no apparent defects in early neural development, and this may be due to the isoform complexity (31, 34) and possible redundancy of function in the mouse. Thus, our studies of Xenopus may provide the first clues to isoform-specific functions of MEF2 family members during embryogenesis.
To date, two regulatory pathways for head development have been proposed. One is a default state that is triggered by inhibiting growth factor signals required for trunk development, such as those induced by Wnt, BMP, and Nodal (5, 8, 18) . The other is an insulin-like growth factor-mediated active pathway involved in anterior head formation (12, 32) . These pathways function in a parallel and/or cooperative manner to promote anteriorizing activity and to suppress the trunk mesoderm. Although the actual ligands that initiate NLK-MEF2A signaling are unclear at present, it is known that NLK is acti- vated by many ligands and stimuli and is involved in mesoderm induction and axis formation through Wnt and transforming growth factor ␤ signaling pathways in early Xenopus development. It is possible that NLK activates MEF2A through the action of a yet-to-be-identified ligand(s) that regulates anterior tissue development, and further studies will be needed to identify the precise ligand(s) involved in this process. It will also be important to determine whether there is cross talk among NLK-MEF2A and other signaling pathways to mediate anterior tissue development.
